AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery

Recruitingn/aAges 18 Years - 75 YearsAllXi Shan Wang
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

To evaluate the efficacy and safety of Huaier granules for Prevention of Recurrence and Metastasis of colorectal cancer patients following radical surgery

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Males or females ages 18-75 years; 2. The first time to the therapy of patients who received the radical surgery within two months, Postoperative histopathology confirms the diagnosis of colorectal cancer with stage IIB, IIC and III ( TNM classification) 3. ECOG score of 0-2; 4. No history of malignant tumors; 5. The patients are volunteered for the study, sign informed consent form and cooperate with Investigator to collect data. Exclusion Criteria: 1. Patients have basic diseases including heart diseases, cerebrovascular disease, lung disease, severe hypertension or diabetes with poor glycemic control; 2. confirmed infections after surgery ; 3. Patients who have post-surgery complications or who are currently under the influence of the radical surgery for colorectal cancer; 4. Being infected with syphilis or with other blood-borne infectious diseases; 5. Pregnancy or lactation; or women of childbearing potential not using contraception; 6. Patients who have taken Traditional Chinese Medicines with efficacy and indications similar to that of Huaier granule - including, but not limited to, compound Banmao capsule., Huachansu capsule, Kangai Injection and Pingxiao tablets; 7. Patients who are suffering from mental illness or Conditions that are considered not suitable for this study investigators.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

22 sites
The Fourth Hospital of Hebei Medical University
Shijiazhuang, China
The First Clinical Hospital affiliated to Harbin Medical University
Harbin, China
The Second Affiliated Hospital of Harbin Medical University
Harbin, China
Hubei Cancer Hospita
Wuhan, China
Union Hospital Tongji College Huazhong University of Science and Technology
Wuhan, China
Hunan Provincial People's Hospital
Changsha, China
Xiangya Hospital Central South University
Changsha, China
Changzhou No.2 People's Hospital
Changzhou, China

โ€ฆand 14 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy